
Phuong N. Huynh
Examiner (ID: 3827, Phone: (571)272-0846 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1641, 1644 |
| Total Applications | 2195 |
| Issued Applications | 1131 |
| Pending Applications | 251 |
| Abandoned Applications | 828 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4657122
[patent_doc_number] => 20080025983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Methods of screening based on the EGF receptor crystal structure'
[patent_app_type] => utility
[patent_app_number] => 11/882679
[patent_app_country] => US
[patent_app_date] => 2007-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 19355
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20080025983.pdf
[firstpage_image] =>[orig_patent_app_number] => 11882679
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/882679 | Methods of screening based on the EGF receptor crystal structure | Aug 2, 2007 | Abandoned |
Array
(
[id] => 4550491
[patent_doc_number] => 07820410
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-26
[patent_title] => 'Proteins with high immunoreactivity and method for their production'
[patent_app_type] => utility
[patent_app_number] => 11/888483
[patent_app_country] => US
[patent_app_date] => 2007-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 9109
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/820/07820410.pdf
[firstpage_image] =>[orig_patent_app_number] => 11888483
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/888483 | Proteins with high immunoreactivity and method for their production | Jul 31, 2007 | Issued |
Array
(
[id] => 122095
[patent_doc_number] => 07704506
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-27
[patent_title] => 'Fcε-PE chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the same'
[patent_app_type] => utility
[patent_app_number] => 11/888167
[patent_app_country] => US
[patent_app_date] => 2007-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 6496
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/704/07704506.pdf
[firstpage_image] =>[orig_patent_app_number] => 11888167
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/888167 | Fcε-PE chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the same | Jul 30, 2007 | Issued |
Array
(
[id] => 4758907
[patent_doc_number] => 20080311133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'METHODS OF USING MULTIVALENT MHC CLASS II-PEPTIDE CHIMERAS'
[patent_app_type] => utility
[patent_app_number] => 11/830465
[patent_app_country] => US
[patent_app_date] => 2007-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7723
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20080311133.pdf
[firstpage_image] =>[orig_patent_app_number] => 11830465
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/830465 | METHODS OF USING MULTIVALENT MHC CLASS II-PEPTIDE CHIMERAS | Jul 29, 2007 | Abandoned |
Array
(
[id] => 5198726
[patent_doc_number] => 20070298044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'Enhancing the efficacy of immunotherapies by supplementing with complement'
[patent_app_type] => utility
[patent_app_number] => 11/881036
[patent_app_country] => US
[patent_app_date] => 2007-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9756
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0298/20070298044.pdf
[firstpage_image] =>[orig_patent_app_number] => 11881036
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/881036 | Enhancing the efficacy of immunotherapies by supplementing with complement | Jul 24, 2007 | Issued |
Array
(
[id] => 4921498
[patent_doc_number] => 20080069813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'ISOLATED BOVINE IgG HEAVY CHAIN PROTEIN AND ITS USE AS AN ANTIMICROBIAL'
[patent_app_type] => utility
[patent_app_number] => 11/777833
[patent_app_country] => US
[patent_app_date] => 2007-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3053
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20080069813.pdf
[firstpage_image] =>[orig_patent_app_number] => 11777833
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/777833 | ISOLATED BOVINE IgG HEAVY CHAIN PROTEIN AND ITS USE AS AN ANTIMICROBIAL | Jul 12, 2007 | Abandoned |
Array
(
[id] => 4687702
[patent_doc_number] => 20080031883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-07
[patent_title] => 'Condition-dependent, multiple target delivery system'
[patent_app_type] => utility
[patent_app_number] => 11/879017
[patent_app_country] => US
[patent_app_date] => 2007-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8112
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20080031883.pdf
[firstpage_image] =>[orig_patent_app_number] => 11879017
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/879017 | Condition-dependent, multiple target delivery system | Jul 12, 2007 | Abandoned |
Array
(
[id] => 5224681
[patent_doc_number] => 20070253947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-01
[patent_title] => 'Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it'
[patent_app_type] => utility
[patent_app_number] => 11/786525
[patent_app_country] => US
[patent_app_date] => 2007-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9433
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20070253947.pdf
[firstpage_image] =>[orig_patent_app_number] => 11786525
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/786525 | Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it | Jul 11, 2007 | Issued |
Array
(
[id] => 9019921
[patent_doc_number] => 08529904
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-10
[patent_title] => 'Immunotherapeutic methods using epitopes of WT-1 and GATA-1'
[patent_app_type] => utility
[patent_app_number] => 11/825578
[patent_app_country] => US
[patent_app_date] => 2007-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 18574
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11825578
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/825578 | Immunotherapeutic methods using epitopes of WT-1 and GATA-1 | Jul 5, 2007 | Issued |
Array
(
[id] => 4658138
[patent_doc_number] => 20080027000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'APO-A-I Regulation of T-Cell Signaling'
[patent_app_type] => utility
[patent_app_number] => 11/774258
[patent_app_country] => US
[patent_app_date] => 2007-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 37308
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20080027000.pdf
[firstpage_image] =>[orig_patent_app_number] => 11774258
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/774258 | APO-A-I Regulation of T-Cell Signaling | Jul 5, 2007 | Abandoned |
Array
(
[id] => 8566058
[patent_doc_number] => 20120328628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-27
[patent_title] => 'ANTIBODIES TO CONFORMATIONALLY TRAPPED PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 12/307906
[patent_app_country] => US
[patent_app_date] => 2007-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 28187
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12307906
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/307906 | ANTIBODIES TO CONFORMATIONALLY TRAPPED PROTEINS | Jul 5, 2007 | Abandoned |
Array
(
[id] => 5501692
[patent_doc_number] => 20090162380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'Multispecific binding molecules comprising connecting peptides'
[patent_app_type] => utility
[patent_app_number] => 11/825666
[patent_app_country] => US
[patent_app_date] => 2007-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 50801
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20090162380.pdf
[firstpage_image] =>[orig_patent_app_number] => 11825666
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/825666 | Multispecific binding molecules comprising connecting peptides | Jul 4, 2007 | Issued |
Array
(
[id] => 6347764
[patent_doc_number] => 20100021379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'Chemical Antibodies for Immunotherapy and Imaging'
[patent_app_type] => utility
[patent_app_number] => 12/306244
[patent_app_country] => US
[patent_app_date] => 2007-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 25507
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20100021379.pdf
[firstpage_image] =>[orig_patent_app_number] => 12306244
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/306244 | Chemical Antibodies for Immunotherapy and Imaging | Jun 27, 2007 | Abandoned |
Array
(
[id] => 8548776
[patent_doc_number] => 08323656
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-04
[patent_title] => 'Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/767775
[patent_app_country] => US
[patent_app_date] => 2007-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13069
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11767775
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/767775 | Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof | Jun 24, 2007 | Issued |
Array
(
[id] => 13965
[patent_doc_number] => 07807789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-05
[patent_title] => 'Reagents for the detection of protein phosphorylation in EGFR-signaling pathways'
[patent_app_type] => utility
[patent_app_number] => 11/821130
[patent_app_country] => US
[patent_app_date] => 2007-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 7
[patent_no_of_words] => 20497
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/807/07807789.pdf
[firstpage_image] =>[orig_patent_app_number] => 11821130
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/821130 | Reagents for the detection of protein phosphorylation in EGFR-signaling pathways | Jun 20, 2007 | Issued |
Array
(
[id] => 4927867
[patent_doc_number] => 20080167230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'Methods and compositions for treating or preventing lesions of the respiratory epithelium'
[patent_app_type] => utility
[patent_app_number] => 11/821367
[patent_app_country] => US
[patent_app_date] => 2007-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8275
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20080167230.pdf
[firstpage_image] =>[orig_patent_app_number] => 11821367
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/821367 | Methods and compositions for treating or preventing lesions of the respiratory epithelium | Jun 20, 2007 | Abandoned |
Array
(
[id] => 4594978
[patent_doc_number] => 07981425
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-19
[patent_title] => 'Thrombopoietic compounds'
[patent_app_type] => utility
[patent_app_number] => 11/820463
[patent_app_country] => US
[patent_app_date] => 2007-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 39430
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/981/07981425.pdf
[firstpage_image] =>[orig_patent_app_number] => 11820463
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/820463 | Thrombopoietic compounds | Jun 17, 2007 | Issued |
Array
(
[id] => 6289961
[patent_doc_number] => 20100158925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'Lyophilized formulations of anti-egfr antibodies'
[patent_app_type] => utility
[patent_app_number] => 12/308451
[patent_app_country] => US
[patent_app_date] => 2007-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5435
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20100158925.pdf
[firstpage_image] =>[orig_patent_app_number] => 12308451
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/308451 | Lyophilized formulations of anti-egfr antibodies | Jun 12, 2007 | Abandoned |
Array
(
[id] => 7766221
[patent_doc_number] => 20120034245
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2012-02-09
[patent_title] => 'SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 12/304562
[patent_app_country] => US
[patent_app_date] => 2007-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 67
[patent_figures_cnt] => 67
[patent_no_of_words] => 71321
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0034/20120034245.pdf
[firstpage_image] =>[orig_patent_app_number] => 12304562
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/304562 | Single chain multivalent binding proteins with effector function | Jun 11, 2007 | Issued |
Array
(
[id] => 7766221
[patent_doc_number] => 20120034245
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2012-02-09
[patent_title] => 'SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 12/304562
[patent_app_country] => US
[patent_app_date] => 2007-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 67
[patent_figures_cnt] => 67
[patent_no_of_words] => 71321
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0034/20120034245.pdf
[firstpage_image] =>[orig_patent_app_number] => 12304562
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/304562 | Single chain multivalent binding proteins with effector function | Jun 11, 2007 | Issued |